171 related articles for article (PubMed ID: 25273894)
1. The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells.
Sachs-Barrable K; Darlington JW; Wasan KM
Lipids Health Dis; 2014 Oct; 13():153. PubMed ID: 25273894
[TBL] [Abstract][Full Text] [Related]
2. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
3. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
4. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
5. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
6. Effects of budesonide on P-glycoprotein expression in intestinal cell lines.
Maier A; Zimmermann C; Beglinger C; Drewe J; Gutmann H
Br J Pharmacol; 2007 Feb; 150(3):361-8. PubMed ID: 17179942
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Use of Human Mouth Epidermal Carcinoma (KB) Cells Overexpressing P-Glycoprotein To Characterize Structure Requirements for Flavonoids Transported by the Efflux Transporter.
Fang Y; Xia M; Liang F; Cao W; Pan S; Xu X
J Agric Food Chem; 2019 Feb; 67(8):2350-2360. PubMed ID: 30688455
[TBL] [Abstract][Full Text] [Related]
8. Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells.
Oga EF; Sekine S; Shitara Y; Horie T
Am J Trop Med Hyg; 2012 Jul; 87(1):64-9. PubMed ID: 22764293
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
Wang PP; Xu DJ; Huang C; Wang WP; Xu WK
Mol Med Rep; 2014 Jun; 9(6):2131-7. PubMed ID: 24676670
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intestinal absorption of cholesterol by surface-modified nanostructured aluminosilicate compounds.
Gershkovich P; Darlington J; Sivak O; Constantinides PP; Wasan KM
J Pharm Sci; 2009 Jul; 98(7):2390-400. PubMed ID: 19090562
[TBL] [Abstract][Full Text] [Related]
11. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.
Yue GG; Cheng SW; Yu H; Xu ZS; Lee JK; Hon PM; Lee MY; Kennelly EJ; Deng G; Yeung SK; Cassileth BR; Fung KP; Leung PC; Lau CB
J Med Food; 2012 Mar; 15(3):242-52. PubMed ID: 22181075
[TBL] [Abstract][Full Text] [Related]
12. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits.
Kajikawa T; Mishima HK; Murakami T; Takano M
Curr Eye Res; 1999 Mar; 18(3):240-6. PubMed ID: 10342379
[TBL] [Abstract][Full Text] [Related]
13. Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity.
Abuznait AH; Patrick SG; Kaddoumi A
J Pharm Pharm Sci; 2011; 14(2):236-48. PubMed ID: 21733412
[TBL] [Abstract][Full Text] [Related]
14. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
18. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
19. The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation.
Senarathna SM; Page-Sharp M; Crowe A
PLoS One; 2016; 11(4):e0152677. PubMed ID: 27045516
[TBL] [Abstract][Full Text] [Related]
20. Reversible inhibition of efflux transporters by hydrogel microdevices.
Levy ES; Samy KE; Lamson NG; Whitehead KA; Kroetz DL; Desai TA
Eur J Pharm Biopharm; 2019 Dec; 145():76-84. PubMed ID: 31639417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]